Abstract

 

This study evaluates the clinical success rate of Megagen AnyRidge dental implants in full-arch restorations across a diverse patient population, including individuals with severe periodontal disease, diabetes, and a history of smoking. Over 500 patients, involving more than 800 arches and 5000 implants, were treated with the AnyRidge system. Our analysis reveals a 99.2% success rate immediately post-surgery and a 97.5% success rate at the three-month loading period with zirconia prosthetics. These findings support the use of Megagen AnyRidge implants as a reliable solution in challenging full-arch cases.

​

Introduction

 

Dental implants have become the gold standard for full-arch rehabilitation, especially in patients with compromised oral health conditions. However, factors such as severe periodontal disease, diabetes, and smoking have historically been associated with higher implant failure rates. The Megagen AnyRidge implant system has been designed to optimize stability and support early loading, even in cases with complex conditions. This study aims to examine the success rates of the AnyRidge system in full-arch restorations under these challenging conditions.

 

Materials and Methods

 

Study Design

 

This retrospective study includes data from 500 patients who received full-arch restorations using Megagen AnyRidge dental implants between 2018 and 2023. A total of 5000 implants were placed across 800 arches.

 

Patient Population

 

The patient sample comprised individuals with various risk factors, including:

 

• Severe periodontal disease

• Diabetes mellitus

• Smoking history

 

Procedure

 

The implant placement was performed using the AnyRidge system, known for its unique thread design and high initial stability. All patients received a provisional prosthesis immediately post-surgery, followed by zirconia final restorations at the three-month mark. Clinical parameters, such as implant stability and peri-implant health, were monitored closely.

 

Outcome Measures

 

Primary outcomes assessed were:

 

• Surgical success rate (measured immediately post-surgery)

• Prosthetic success rate (measured at the three-month loading period with zirconia restorations)

 

Data Analysis

 

Success rates were calculated for each time point, with implant survival defined as the absence of mobility, pain, and infection. Statistical analysis was conducted using descriptive statistics to determine the overall success rates for this patient population.

 

Results

 

• Surgical Success Rate: Out of the 5000 implants placed, 4960 were successful immediately post-surgery, resulting in a 99.2% surgical success rate.

• Three-Month Loading Success Rate: At the three-month follow-up, when final zirconia restorations were placed, 4875 of the implants remained stable and free from complications, yielding a 97.5% success rate.

 

Patient Risk Subgroup Analysis

 

Despite the high-risk nature of the patient cohort, success rates were consistently high:

 

• Patients with severe periodontal disease: 99.1% surgical success, 97.3% loading success

• Diabetic patients: 98.9% surgical success, 97.1% loading success

• Smokers: 98.5% surgical success, 96.9% loading success

 

These results demonstrate the robustness of the AnyRidge system in achieving high success rates, even in patients traditionally considered challenging candidates for implant therapy.

 

Discussion

 

This study demonstrates that the Megagen AnyRidge implant system provides high success rates in full-arch restorations for patients with complex health conditions. The innovative design of the AnyRidge implants, particularly the tapered body and sharp thread, likely contributes to enhanced primary stability, allowing for predictable outcomes in immediate loading protocols.

 

The high success rates seen in patients with periodontal disease, diabetes, and smoking history are particularly noteworthy, as these conditions have been correlated with higher risks of implant failure. The 99.2% surgical success rate observed aligns well with other studies involving healthy patients, underscoring the potential of the AnyRidge system to support challenging cases.

 

The slight decrease in success rate at the three-month mark (97.5%) is attributed primarily to biological complications, including peri-implantitis, observed in patients with severe systemic conditions. Further research is recommended to explore specific management strategies for such complications.

 

Conclusion

 

The Megagen AnyRidge implant system achieved a 99.2% surgical success rate and a 97.5% success rate after three months in a high-risk patient population. This study supports the use of AnyRidge implants for full-arch restorations, even in patients with severe periodontal disease, diabetes, and smoking habits. The AnyRidge system proves to be a viable and reliable option for complex cases, potentially setting a new standard in implantology for compromised patients.

 

Acknowledgments

 

We extend our gratitude to the clinicians, staff, and patients who contributed to this study. Special thanks to the New Life Dental Implant Center for their commitment to advancing the field of implant dentistry.